Loading...

Categories

11 Brazil Hyperglycemics Reports

Latin America Biguanide Industry

Country Covered: Brazil

Study Period: 2018 - 2029

Major Players: Bristol-Myers Squibb, Boehringer Ingelheim, Merck and Co., Sanofi Aventis, Glenmark Pharmaceuticals

Latin America Human Insulin Drugs Industry

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Pfizer

Latin America Meglitinide Industry

Country Covered: Brazil

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Meglitinides Market

Country Covered: Brazil

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

SGLT2 Inhibitors Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Fibrate Drugs Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma

Glargine Insulin Market

Country Covered: Brazil

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Insulin Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Sanofi, Biocon

Sulfonylureas Industry

Country Covered: Brazil

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

Biguanides Market

Country Covered: Brazil

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.